NCT03847636View on ClinicalTrials.gov

CryoBalloon Ablation for Treatment of Duodenal Adenomas

NAActive, not recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

March 1, 2025

Study Completion Date

March 31, 2026

Conditions
Duodenal AdenomasFamilial Adenomatous Polyposis
Interventions
DEVICE

CryoBalloon ablation

Endoscopic cryoablation (cryogen is contained nitrous) using a CryoBalloon catheter to ablate up to 4 separate DA.

Trial Locations (4)

11030

Northwell Health, Manhasset

17822

Geisinger Medical Center, Danville

21287

Johns Hopkins Hospital, Baltimore

75203

Methodist Dallas Medical Center, Dallas

Sponsors

Collaborators (1)

Pentax Medical
All Listed Sponsors
collaborator

Pentax Medical

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT03847636 - CryoBalloon Ablation for Treatment of Duodenal Adenomas | Biotech Hunter | Biotech Hunter